Market Cap for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported market cap is $46.50B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$46.50B
YoY change
-5.6%
5Y CAGR
-10.4%
Peak year (2021)
$81.77B
Latest annual
$47.16B
Market Cap history chart for Edwards Lifesciences (EW) from 2000 to 2026
Market Cap history table for Edwards Lifesciences (EW) from 2000 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $47.16B | -5.6% | ||
| 2025 | $49.94B | +12.6% | ||
| 2024 | $44.37B | -4.5% | ||
| 2023 | $46.47B | -0.2% | ||
| 2022 | $46.57B | -43.0% | ||
| 2021 | $81.77B | +41.8% | ||
| 2020 | $57.65B | +16.5% | ||
| 2019 | $49.50B | +51.3% | ||
| 2018 | $32.72B | +34.4% | ||
| 2017 | $24.33B | +19.2% | ||
| 2016 | $20.41B | +17.3% | ||
| 2015 | $17.40B | +25.9% | ||
| 2014 | $13.82B | +84.7% | ||
| 2013 | $7.48B | -29.8% | ||
| 2012 | $10.67B | +26.4% | ||
| 2011 | $8.44B | -12.4% | ||
| 2010 | $9.64B | +89.0% | ||
| 2009 | $5.10B | +55.7% | ||
| 2008 | $3.28B | +13.6% | ||
| 2007 | $2.88B | -4.1% | ||
| 2006 | $3.01B | +16.0% | ||
| 2005 | $2.59B | +1.3% | ||
| 2004 | $2.56B | +39.2% | ||
| 2003 | $1.84B | +17.7% | ||
| 2002 | $1.56B | -4.1% | ||
| 2001 | $1.63B | +57.8% | ||
| 2000 | $1.03B | — |
Market Cap values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2026 fiscal year, Edwards Lifesciences (EW) reported market cap of $47.16B – declined 5.6% year-over-year.
Edwards Lifesciences market cap compound annual growth for the 2021–2026 (5 years) window is -10.4%, with a net decline across the window.
Edwards Lifesciences market cap plunged from $81.77B in 2021 to $47.16B in 2026, a 42.3% drawdown.
$81.77B stands as the all-time-high annual market cap, posted in 2021, against a low of $1.03B during 2000.
Among 8 Healthcare peers, Edwards Lifesciences (EW) ranks 9th; the peer median for market cap is $311.16B.
Edwards Lifesciences Market Cap by Year
Edwards Lifesciences Market Cap 2026: $47.16B
Edwards Lifesciences market cap in 2026 was $47.16B, declined 5.6% below 2025.
Edwards Lifesciences Market Cap 2025: $49.94B
Edwards Lifesciences market cap in 2025 was $49.94B, grew 12.6% from 2024.
Edwards Lifesciences Market Cap 2024: $44.37B
Edwards Lifesciences market cap in 2024 was $44.37B, edged down 4.5% below 2023.
Edwards Lifesciences Market Cap 2023: $46.47B
Edwards Lifesciences market cap in 2023 was $46.47B, edged down 0.2% below 2022.
Edwards Lifesciences Market Cap 2022: $46.57B
Edwards Lifesciences market cap in 2022 was $46.57B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Market Cap
Companies in the same sector as Edwards Lifesciences, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's market cap?
- Latest reported market cap for Edwards Lifesciences (EW) is $46.50B (period ending March 31, 2026).
How has Edwards Lifesciences market cap changed year-over-year?
- Edwards Lifesciences (EW) market cap changed -5.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences market cap?
- Edwards Lifesciences (EW) market cap compound annual growth rate is -10.4% over the most recent 5 years available.
When did Edwards Lifesciences market cap hit its highest annual value?
- Edwards Lifesciences market cap reached its highest annual value of $81.77B in 2021.
What was Edwards Lifesciences market cap in 2025?
- Edwards Lifesciences (EW) market cap in 2025 was $49.94B.
What was Edwards Lifesciences market cap in 2026?
- Edwards Lifesciences (EW) market cap in 2026 was $47.16B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.